Art joined Royalty Pharma in 2022. Previously, Art was a partner in Goodwin Procter’s Life Sciences practice. Art holds a BS in civil engineering from Tufts University and a JD from Boston University.
Art joined Royalty Pharma in 2022. Previously, Art was a partner in Goodwin Procter’s Life Sciences practice. Art holds a BS in civil engineering from Tufts University and a JD from Boston University.
